Tmunity Therapeutics' Seed VC - II Round

Tmunity Therapeutics raised a round of funding on February 05, 2016.

Tmunity Therapeutics is developing novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms that exhibit control over T cell activation and …

Articles about Tmunity Therapeutics' Seed VC - II Round: